Research Progress on Ferroptosis-Inducing Compounds in Tumor Cells
Die Pharmazie · 2026
DOI: 10.31083/pharmazie51559 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Die Pharmazie, 2026. Verfasst von Ruiyuan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Jiamusi University, 154007 Jiamusi, Heilongjiang, China. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ferroptosis is a regulated form of cell death characterized by iron-dependent lipid peroxidation. Intracellular iron promotes the generation of reactive oxygen species via the Fenton reaction, leading to lipid peroxide accumulation, membrane damage, and subsequent cell death. Increasing evidence indicates that ferroptosis plays a critical role in cancer progression and therapeutic response. Recent studies have identified a diverse range of ferroptosis-inducing compounds, including natural products, semi-synthetic derivatives, and synthetic small molecules, which exert antitumor effects by targeting key regulatory nodes such as iron metabolism, system Xc-, and glutathione peroxidase 4. However, the clinical translation of ferroptosis-based strategies remains limited by insufficient tumor selectivity, systemic toxicity, the lack of reliable biomarkers, and adaptive resistance mechanisms. In this review, we summarize the molecular regulatory networks governing ferroptosis, critically evaluate representative ferroptosis-inducing compounds and the associated mechanisms of action, and discuss current translational challenges and unresolved controversies. Furthermore, an integrative framework is proposed to define ferroptosis as a context-dependent metabolic vulnerability in tumors, thereby providing a conceptual basis for the rational development of ferroptosis-based anticancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Jiamusi University, 154007 Jiamusi, Heilongjiang, China.
- Department of Basic Medicine, School of Medicine, Taizhou University, 318000 Taizhou, Zhejiang, China.
Zitieren
APA
Zhang, R., Xu, M., Li, M., Xu, M., Han, X., & Hu, Q. (2026). Research Progress on Ferroptosis-Inducing Compounds in Tumor Cells. Die Pharmazie. https://doi.org/10.31083/pharmazie51559
Vancouver
Zhang R, Xu M, Li M, Xu M, Han X, Hu Q. Research Progress on Ferroptosis-Inducing Compounds in Tumor Cells. Die Pharmazie. 2026. doi:10.31083/pharmazie51559
BibTeX
@article{Zhang2026,
author = {Zhang, Ruiyuan and Xu, Meiyun and Li, Mansa and Xu, Manyu and Han, Xi and Hu, Qiongying},
title = {Research Progress on Ferroptosis-Inducing Compounds in Tumor Cells},
journal = {Die Pharmazie},
year = {2026},
doi = {10.31083/pharmazie51559}
}
EUVIMED